Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e non » _ non (Expand Search), a non (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e non » _ non (Expand Search), a non (Expand Search)
-
201
-
202
-
203
-
204
Efficacy of an herbal compound in decreasing steatosis and transaminase activities in non-alcoholic fatty liver disease: A randomized clinical trial
Published 2022“…<div><p>Abstract Hepatoprotective effects of many herbal agents have been reported in animal studies and clinical trials. In this study, five hepatoprotective plants with potent antioxidant, anti-inflammatory, and hypolipidemic effects were chosen to prepare a polyherbal compound for managing NAFLD. …”
-
205
-
206
-
207
-
208
-
209
Decrease in health can be partly compensated by homeostatic mechanisms and be invisible from the statistical properties of background activity, as shown by the behavior on an excit...
Published 2020“…<p><b>A</b>. For such a network, changes in the neuronal health, modeled by a decrease in the <i>α</i> parameter, do not appear in the background activity of the raster (non-grayed areas), where the activity of both excitatory (red circles) and inhibitory (gray triangles) neurons remain very similar. …”
-
210
-
211
-
212
-
213
Prolonged starvation leads to a delay in cell cycle re-entry and decrease in H3K27ac in Vasa2+/Piwi1+ cells.
Published 2025“…Significance levels after one-way ANOVA with Tukey’s HSD for pairwise comparisons are indicated for adjusted <i>p</i> values: *<i>p < </i>0.05, **<i>p < </i>0.01; ****<i>p < </i>0.0001. d: day(s), n.s.: non-significant. See <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003525#pbio.3003525.s016" target="_blank">S5</a> and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003525#pbio.3003525.s017" target="_blank">S6 Tables</a> for mean values and statistical data and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003525#pbio.3003525.s020" target="_blank">S1 Data</a> for individual numerical values.…”
-
214
-
215
-
216
Image8_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF
Published 2022“…Meanwhile, enhancers transcript non-coding RNAs, known as enhancer RNAs (eRNAs), which may serve as potential diagnosis markers and therapeutic targets in Ewing sarcoma.…”
-
217
Image10_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF
Published 2022“…Meanwhile, enhancers transcript non-coding RNAs, known as enhancer RNAs (eRNAs), which may serve as potential diagnosis markers and therapeutic targets in Ewing sarcoma.…”
-
218
Table1_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.DOCX
Published 2022“…Meanwhile, enhancers transcript non-coding RNAs, known as enhancer RNAs (eRNAs), which may serve as potential diagnosis markers and therapeutic targets in Ewing sarcoma.…”
-
219
Image9_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF
Published 2022“…Meanwhile, enhancers transcript non-coding RNAs, known as enhancer RNAs (eRNAs), which may serve as potential diagnosis markers and therapeutic targets in Ewing sarcoma.…”
-
220
Image12_Repression of enhancer RNA PHLDA1 promotes tumorigenesis and progression of Ewing sarcoma via decreasing infiltrating T‐lymphocytes: A bioinformatic analysis.TIF
Published 2022“…Meanwhile, enhancers transcript non-coding RNAs, known as enhancer RNAs (eRNAs), which may serve as potential diagnosis markers and therapeutic targets in Ewing sarcoma.…”